Multidimensional Roles of EZH2 and Its Therapeutic Potential in Cancer TherapyReview Article
Life Conflux · 2025
DOI: 10.71321/q01vae55 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Conflux, 2025. Verfasst von Hui Yin und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Enhancer of zeste homolog 2 (EZH2), a core member of the Polycomb Group (PcG) family, is a pivotal epigenetic regulator. As the catalytic subunit of Polycomb Repressive Complex 2 (PRC2), EZH2 mediates trimethylation of histone H3 lysine 27 (H3K27me3), leading to chromatin condensation and altered expression of downstream genes. This mechanism enables EZH2 to exert multidimensional roles in development, tumors, immunity, and the nervous system. Given its critical role in epigenetic regulation and multidimensional oncogenesis, EZH2 has emerged as a hot target for cancer therapy. This review summarizes EZH2's regulatory functions and specific pro-tumorigenic mechanisms, detailing its roles in epigenetic regulation, tumor proliferation and metastasis, tumor microenvironment, stemness maintenance, drug resistance, metabolic reprogramming, and dysregulated signaling pathways, aiming to inspire new perspectives in cancer treatment research.
Zitieren
APA
Yin, H., Tan, J., He, J., Li, M., & Lin, H. (2025). Multidimensional Roles of EZH2 and Its Therapeutic Potential in Cancer TherapyReview Article. Life Conflux. https://doi.org/10.71321/q01vae55
Vancouver
Yin H, Tan J, He J, Li M, Lin H. Multidimensional Roles of EZH2 and Its Therapeutic Potential in Cancer TherapyReview Article. Life Conflux. 2025. doi:10.71321/q01vae55
BibTeX
@article{Yin2025,
author = {Yin, Hui and Tan, Jinna and He, Jiaqian and Li, Mingfen and Lin, Hongsheng},
title = {Multidimensional Roles of EZH2 and Its Therapeutic Potential in Cancer TherapyReview Article},
journal = {Life Conflux},
year = {2025},
doi = {10.71321/q01vae55}
}
EUVIMED